Dr. Sajjan Rajpurohit
Senior Director
• Oncology
• 22+ years of experience
• BLK MAX Hospital, Delhi
Brief about doctor
Dr. Sajjan Rajpurohit is a well-known medical oncologist with over 22 years of experience. He has done his DNB in Medical Oncology from Rajiv Gandhi Cancer Institute & Research Centre (RGCI & RC), New Delhi, and had further specialized training in immuno-oncology at the MD Anderson Cancer Center in Houston, USADr. Rajpurohit is one of the pioneers of immunotherapy. To date, he has conducted more than 15,000 immunotherapy cycles and hence has immense expertise in the subject. His major area of specialty is managing intricate cancer cases. He also finds precision oncology highly fascinating. His presentations were invited for a number of national and international conferences. Additionally, his articles are published in the most distinguished journals across the world.
Work Experience
- Senior Director, Medical Oncology, BLK-Max Super Speciality Hospital, New Delhi.
- Max Multi-Speciality Centre
- Principal Consultant & Head, Medical Oncology,
- Rajiv Gandhi Cancer Institute
- Consultant and Unit Head, Medical Oncology
- Editor-in-Chief: Clinical Oncology, Textbook of Oncology, Theme Publications, Germany.
- Managing Editor, Asian Journal of Oncology.
- Consultant, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi.
- National Faculty for Postgraduate Teaching—Dr. Bhatia Institute for MD/MS.
- Medical Director, Mansaram Hospital.
Education & Training
- DNB (Medical Oncology): Rajiv Gandhi Cancer Institute & Research Centre, New Delhi.
- MD (Medicine): Maulana Azad Medical College, New Delhi.
- MBBS: Maulana Azad Medical College, New Delhi.
- Immuno-oncology training: MD Anderson Cancer Center, Houston, USA.
- ESMO Immuno-Oncology Perceptorship - Geneva.
- ESMO Neuroendocrine Tumor Preceptorship - Singapore.
- European Certified Medical Oncologist - European Society for Medical Oncology (ESMO), Geneva.
Memberships
- Life Member - Indian Society of Medical and Pediatric Oncology (ISMPO).
- Life Member - Indian Cooperative Oncology Network (ICON).
- Group Treasurer - Young Oncologist Group.
- Member - National Academy of Medical Sciences (NAMS).
- Member - European Society for Medical Oncology (ESMO).
- Member - American Society of Clinical Oncology (ASCO).
Awards and Achievements
- First to use immunotherapy in India in oncology.
- Targeted therapy for the treatment of cancers.
- He is known for managing chemotherapy in solid tumors such as breast, lung, gastrointestinal, genitourinary, head and neck cancers, and sarcomas.
- Specializes in managing complex cancer cases and intensive protocols.
Specialty Interests
- Immunotherapy in Oncology.
- Targeted Therapy for Cancer.
- Chemotherapy for Solid Tumors (Breast, Lung, Gastrointestinal, Genitourinary, Head & Neck, Sarcoma).
- Managing Complex Cancer Cases with Advanced Protocols.
Frequently Asked Questions
Q. 1: What types of cancers does Dr. Sajjan Rajpurohit specialize in treating?
Dr. Rajpurohit is an expert in the treatment of solid tumors, including breast, lung, gastrointestinal, genitourinary, head and neck cancers, and sarcomas.
Q. 2: What is immunotherapy, and how is it applied in cancer treatment?
Immunotherapy is a form of treatment that assists the immune system in fighting cancer. Dr. Rajpurohit has extensive experience in this area, having completed more than 15,000 immunotherapy cycles.
Q. 3: Can Dr. Rajpurohit treat complex and rare cancer cases?
Yes, Dr. Rajpurohit is highly skilled in managing complex and rare cancer cases with advanced and personalized treatment protocols.
Q. 4: What is precision oncology, and how does Dr. Rajpurohit use it?
Precision oncology is a way of tailoring the treatment of cancer specifically to the characteristics of that patient's tumor. Dr. Rajpurohit employs precision oncology as a means of providing that highly effective care.
Q. 5: Do medical research and publications involve Dr. Rajpurohit?
Yes, Dr. Rajpurohit has contributed to several national and international medical publications and is an editor for various oncology-related journals.
